Company Name or Ticker Symbol
Search for other Categories

Celgene Corp  (CELG)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations


Celgene Corp

CELG's Financial Statements and Analysis

Celgene Corp reported in I. Quarter net earnings per share of $1.16 an increase by 0 % year on year from $0.99 and an improvement of 0 % from $0.53 realized in IV. Quarter (Dec 31 2016).

Celgene's Revenue rose by % in I. Quarter (Mar 31 2017) year on year, to $2,960 million and declined by -0.69 % sequentially.

Celgene is
More on CELG's Income Statement

I. Quarter
Earnings Per Share Revenues
$ 1.16 $  2,960 Mill
$+0.17     +17.17 % $+448M     +17.85 %
You need to upgrade your Flash Player

  • REVLIMID 11.81% Y/Y,
• ABRAXANE 8.34% Y/Y,
• Other 350% Y/Y,
• Total product sales 18.18% Y/Y,
• ISTODAX 10.19% Y/Y,
• azacitidine injection 7.04% Y/Y
  • THALOMID -13.1% Y/Y,
• VIDAZA -6.46% Y/Y

CELG's Segments


Celgene's net income of $941 million in I. Quarter increased by 17.52 % from net earnings of $801 million achieved in I. Quarter a year ago.

Sequentially net earnings grew by 119.4 % from net income of $428.90 million realized in previous quarter.

More on CELG's Growth

Inventories Inventories grew by 8.16 % to $509 million from I. Quarter a year ago, sequentially inventories rose by 2.23 %. In I. Quarter company's net cash and cash equivalents decreased by $-897 million, capital expenditures fell by 4.03%, to $-62 millions compare to same quarter a year ago and rose by -6.63% from IV. Quarter (Dec 31 2016).

More on CELG's Cash flow Statement

Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 4.53 cash per share, on a free-cash flow basis 171.09 % of net earning per share.

Book value grew by 14.59 % sequentially to $9.42 per share, 118.29% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -9.28 per share from $ -10.79.

Company issued 8.70 million shares or 1.08 % in I. Quarter.
Interest Coverage Ratio was 5.9. Debt Coverage Ratio was 0.21.

More on CELG's Dividends
 Market Capitalization (Millions) 108,952
 Shares Outstanding (Millions) 811
 Total Debt (Millions $) 14,284
 Revenue (TTM) (Millions $) 11,678
 Net Income (TTM) (Millions $) 2,140
 Cash Flow (TTM) (Millions $) 827
 Capital Exp. (TTM) (Millions $) -239
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com